Focus formation: a cell-based assay to determine the oncogenic potential of a gene

Angel Alvarez1, Gustavo A Barisone1, Elva Diaz2

  • 1Department of Pharmacology, University of California, Davis.

Insights

The Focus Formation Assay (FFA) uses retroviral transduction to introduce genes into NIH 3T3 cells, enabling assessment of oncogenic potential by quantifying cell foci. This method efficiently determines cellular transformation and oncogene activity.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Cellular transformation involves hallmarks like increased proliferation and loss of contact inhibition.
  • The Ras signaling pathway is crucial in triggering these transformation events.
  • Assessing oncogenic potential requires reliable methods to detect cellular transformation.

Purpose of the Study:

  • To describe the Focus Formation Assay (FFA) protocol for evaluating oncogene transforming potential.
  • To detail the use of retroviral transduction for efficient gene delivery into NIH 3T3 cells.
  • To explain the quantification of transformed foci via staining.

Main Methods:

  • Utilizing NIH 3T3 cells for transformation assays.
  • Employing retroviral transduction for introducing genes of interest.
  • Visualizing and quantifying transformed foci using crystal violet or Hema 3 staining.

Main Results:

  • Retroviral transduction proved more efficient for gene delivery compared to transfection.
  • The FFA protocol allows for the visualization and quantification of multilayered cell foci.
  • Ecotropic murine retrovirus provides a biosafety control for working with potential human oncogenes.

Conclusions:

  • The Focus Formation Assay is a straightforward method to assess one aspect of oncogene transforming potential.
  • Retroviral transduction is an effective and efficient gene delivery method for transformation studies.
  • This protocol provides a standardized approach for evaluating oncogenes in NIH 3T3 cells.